The table below shows Editas Medicine, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$23.06M
-$47.80M
-$49.87M
-$35.77M
-$49.23M
-$49.48M
Capital expenditure
$92.00K
$114.00K
$1.87M
$1.84M
$2.25M
$84.00K
Investing cash flow
$64.00K
$56.39M
-$4.75M
$23.27M
$56.37M
$3.24M
Dividends paid
-
-
-
-
EDIT operating cash flow (10-K history)
Editas Medicine, Inc. reported operating cash flow of -$165.24M for fiscal year 2025. That is up 21.4% from -$210.28M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$50.25M (FY 2016) to -$165.24M. Figures come from the company's audited annual reports as filed with the SEC.